Exploratory analysis of requests for authorization to dispense high-cost medication to COPD patients: the São Paulo “protocol”

ABSTRACT Objective: A resolution passed by the government of the Brazilian state of São Paulo established a protocol for requesting free COPD medications, including tiotropium bromide, creating regional authorization centers to evaluate and approve such requests, given the high cost of those medications. Our objective was to analyze the requests received by an authorization center that serves cities in the greater metropolitan area of (the city of) São Paulo between 2011 and 2016. Methods: Data regarding the authorization, return, or rejection of the requests were compiled and analyzed in order to explain those outcomes. Subsequently, the clinical and functional data related to the patients were evaluated. Results: A total of 7,762 requests for dispensing COPD medication were analyzed. Requests related to male patients predominated. Among the corresponding patients, the mean age was 66 years, 12% were smokers, 88% had frequent exacerbations, and 84% had severe/very severe dyspnea. The mean FEV1 was 37.2% of the predicted value. The total number of requests decreased by 24.5% from 2012 to 2013 and was lowest in 2015. Most (65%) of the requests were accepted. The main reasons for the rejection/return of a request were a post-bronchodilator FEV1/FVC ratio > 0.7, a post-bronchodilator FEV1 > 50% of the predicted value, and failure to provide information regarding previous use of a long-acting β2 agonist. During the study period, the total number of requests returned/rejected decreased slightly, and there was improvement in the quality of the data included on the forms. Conclusions: Here, we have identified the characteristics of the requests for COPD medications and of the corresponding patients per region served by the authorization center analyzed, thus contributing to the improvement of local public health care measures.

Saved in:
Bibliographic Details
Main Authors: Carvalho-Pinto,Regina Maria, Silva,Ingredy Tavares da, Navacchia,Lucas Yoshio Kido, Granja,Flavia Munhos, Marques,Gustavo Garcia, Nery,Telma de Cassia dos Santos, Fernandes,Frederico Leon Arrabal, Cukier,Alberto, Stelmach,Rafael
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Pneumologia e Tisiologia 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132019000600400
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1806-37132019000600400
record_format ojs
spelling oai:scielo:S1806-371320190006004002019-12-10Exploratory analysis of requests for authorization to dispense high-cost medication to COPD patients: the São Paulo “protocol”Carvalho-Pinto,Regina MariaSilva,Ingredy Tavares daNavacchia,Lucas Yoshio KidoGranja,Flavia MunhosMarques,Gustavo GarciaNery,Telma de Cassia dos SantosFernandes,Frederico Leon ArrabalCukier,AlbertoStelmach,Rafael Pulmonary disease, chronic obstructive Clinical protocols Drug costs Tiotropium bromide ABSTRACT Objective: A resolution passed by the government of the Brazilian state of São Paulo established a protocol for requesting free COPD medications, including tiotropium bromide, creating regional authorization centers to evaluate and approve such requests, given the high cost of those medications. Our objective was to analyze the requests received by an authorization center that serves cities in the greater metropolitan area of (the city of) São Paulo between 2011 and 2016. Methods: Data regarding the authorization, return, or rejection of the requests were compiled and analyzed in order to explain those outcomes. Subsequently, the clinical and functional data related to the patients were evaluated. Results: A total of 7,762 requests for dispensing COPD medication were analyzed. Requests related to male patients predominated. Among the corresponding patients, the mean age was 66 years, 12% were smokers, 88% had frequent exacerbations, and 84% had severe/very severe dyspnea. The mean FEV1 was 37.2% of the predicted value. The total number of requests decreased by 24.5% from 2012 to 2013 and was lowest in 2015. Most (65%) of the requests were accepted. The main reasons for the rejection/return of a request were a post-bronchodilator FEV1/FVC ratio > 0.7, a post-bronchodilator FEV1 > 50% of the predicted value, and failure to provide information regarding previous use of a long-acting β2 agonist. During the study period, the total number of requests returned/rejected decreased slightly, and there was improvement in the quality of the data included on the forms. Conclusions: Here, we have identified the characteristics of the requests for COPD medications and of the corresponding patients per region served by the authorization center analyzed, thus contributing to the improvement of local public health care measures.info:eu-repo/semantics/openAccessSociedade Brasileira de Pneumologia e TisiologiaJornal Brasileiro de Pneumologia v.45 n.6 20192019-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132019000600400en10.1590/1806-3713/e20180355
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Carvalho-Pinto,Regina Maria
Silva,Ingredy Tavares da
Navacchia,Lucas Yoshio Kido
Granja,Flavia Munhos
Marques,Gustavo Garcia
Nery,Telma de Cassia dos Santos
Fernandes,Frederico Leon Arrabal
Cukier,Alberto
Stelmach,Rafael
spellingShingle Carvalho-Pinto,Regina Maria
Silva,Ingredy Tavares da
Navacchia,Lucas Yoshio Kido
Granja,Flavia Munhos
Marques,Gustavo Garcia
Nery,Telma de Cassia dos Santos
Fernandes,Frederico Leon Arrabal
Cukier,Alberto
Stelmach,Rafael
Exploratory analysis of requests for authorization to dispense high-cost medication to COPD patients: the São Paulo “protocol”
author_facet Carvalho-Pinto,Regina Maria
Silva,Ingredy Tavares da
Navacchia,Lucas Yoshio Kido
Granja,Flavia Munhos
Marques,Gustavo Garcia
Nery,Telma de Cassia dos Santos
Fernandes,Frederico Leon Arrabal
Cukier,Alberto
Stelmach,Rafael
author_sort Carvalho-Pinto,Regina Maria
title Exploratory analysis of requests for authorization to dispense high-cost medication to COPD patients: the São Paulo “protocol”
title_short Exploratory analysis of requests for authorization to dispense high-cost medication to COPD patients: the São Paulo “protocol”
title_full Exploratory analysis of requests for authorization to dispense high-cost medication to COPD patients: the São Paulo “protocol”
title_fullStr Exploratory analysis of requests for authorization to dispense high-cost medication to COPD patients: the São Paulo “protocol”
title_full_unstemmed Exploratory analysis of requests for authorization to dispense high-cost medication to COPD patients: the São Paulo “protocol”
title_sort exploratory analysis of requests for authorization to dispense high-cost medication to copd patients: the são paulo “protocol”
description ABSTRACT Objective: A resolution passed by the government of the Brazilian state of São Paulo established a protocol for requesting free COPD medications, including tiotropium bromide, creating regional authorization centers to evaluate and approve such requests, given the high cost of those medications. Our objective was to analyze the requests received by an authorization center that serves cities in the greater metropolitan area of (the city of) São Paulo between 2011 and 2016. Methods: Data regarding the authorization, return, or rejection of the requests were compiled and analyzed in order to explain those outcomes. Subsequently, the clinical and functional data related to the patients were evaluated. Results: A total of 7,762 requests for dispensing COPD medication were analyzed. Requests related to male patients predominated. Among the corresponding patients, the mean age was 66 years, 12% were smokers, 88% had frequent exacerbations, and 84% had severe/very severe dyspnea. The mean FEV1 was 37.2% of the predicted value. The total number of requests decreased by 24.5% from 2012 to 2013 and was lowest in 2015. Most (65%) of the requests were accepted. The main reasons for the rejection/return of a request were a post-bronchodilator FEV1/FVC ratio > 0.7, a post-bronchodilator FEV1 > 50% of the predicted value, and failure to provide information regarding previous use of a long-acting β2 agonist. During the study period, the total number of requests returned/rejected decreased slightly, and there was improvement in the quality of the data included on the forms. Conclusions: Here, we have identified the characteristics of the requests for COPD medications and of the corresponding patients per region served by the authorization center analyzed, thus contributing to the improvement of local public health care measures.
publisher Sociedade Brasileira de Pneumologia e Tisiologia
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132019000600400
work_keys_str_mv AT carvalhopintoreginamaria exploratoryanalysisofrequestsforauthorizationtodispensehighcostmedicationtocopdpatientsthesaopauloprotocol
AT silvaingredytavaresda exploratoryanalysisofrequestsforauthorizationtodispensehighcostmedicationtocopdpatientsthesaopauloprotocol
AT navacchialucasyoshiokido exploratoryanalysisofrequestsforauthorizationtodispensehighcostmedicationtocopdpatientsthesaopauloprotocol
AT granjaflaviamunhos exploratoryanalysisofrequestsforauthorizationtodispensehighcostmedicationtocopdpatientsthesaopauloprotocol
AT marquesgustavogarcia exploratoryanalysisofrequestsforauthorizationtodispensehighcostmedicationtocopdpatientsthesaopauloprotocol
AT nerytelmadecassiadossantos exploratoryanalysisofrequestsforauthorizationtodispensehighcostmedicationtocopdpatientsthesaopauloprotocol
AT fernandesfredericoleonarrabal exploratoryanalysisofrequestsforauthorizationtodispensehighcostmedicationtocopdpatientsthesaopauloprotocol
AT cukieralberto exploratoryanalysisofrequestsforauthorizationtodispensehighcostmedicationtocopdpatientsthesaopauloprotocol
AT stelmachrafael exploratoryanalysisofrequestsforauthorizationtodispensehighcostmedicationtocopdpatientsthesaopauloprotocol
_version_ 1756431129658785792